Heather Chalfin

Presentation(s):

• MP49-03: Circulating Tumor Cell Subtypes and Baseline T-cell Population as Prognostic Biomarkers to Combination Therapy with Cabozantinib, Nivolumab, and Ipilimumab in Metastatic Genitourinary Cancer Patients

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• PD02-01: A Novel Multiplex Score to Predict Outcomes of Partial Nephrectomy for Multiple Tumors

  Friday, May 15, 2020
  7:00 AM – 9:00 AM

• PD51-03: DIGITAL PATHOLOGY OF CIRCULATING TUMOR CELLS WITH MORPHOLOGIC ANALYSIS IS FEASIBLE IN LOCALIZED BLADDER CANCER

  Friday, May 15, 2020
  7:00 AM – 9:00 AM